Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia

Clinical trial NCT01644474 · COMPLETED

Trial details

NCT number: NCT01644474
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2012-07-01
Primary completion: 2013-07-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.